Constellation Pharmaceuticals (CNST) PT Raised to $40 at Brookline Capital Markets
Tweet Send to a Friend
Brookline Capital Markets analyst Leah Rush Cann raised the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $40.00 (from $33.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
